0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI In Clinical Trials Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29K15279
Home | Market Reports | Health| Health Foundations & Medical Research
Global AI In Clinical Trials Market Research Report 2023
BUY CHAPTERS

Global AI In Clinical Trials Market Research Report 2025

Code: QYRE-Auto-29K15279
Report
May 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI In Clinical Trials Market Size

The global market for AI In Clinical Trials was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 82.4 million by 2031, growing at a CAGR of 6.8% during the forecast period.

AI In Clinical Trials Market

AI In Clinical Trials Market

The AI in Clinical Trials market is experiencing significant growth and is expected to continue to expand in the coming years. AI, or artificial intelligence, is being increasingly utilized in the field of clinical trials to enhance various aspects of the trial process, including patient recruitment, data analysis, and drug development.One major trend in the AI in Clinical Trials market is the use of machine learning algorithms to improve patient recruitment and retention. AI algorithms can analyze large amounts of patient data and identify potential candidates for clinical trials more efficiently and accurately than traditional methods. This can help accelerate the recruitment process and ensure that trials have a diverse and representative patient population.
This report aims to provide a comprehensive presentation of the global market for AI In Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Clinical Trials.
The AI In Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI In Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI In Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI In Clinical Trials Market Report

Report Metric Details
Report Name AI In Clinical Trials Market
Accounted market size in year US$ 52.3 million
Forecasted market size in 2031 US$ 82.4 million
CAGR 6.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Software
  • Service
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn Al, PathAl, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs lInc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI In Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AI In Clinical Trials Market growing?

Ans: The AI In Clinical Trials Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the AI In Clinical Trials Market size in 2031?

Ans: The AI In Clinical Trials Market size in 2031 will be US$ 82.4 million.

Who are the main players in the AI In Clinical Trials Market report?

Ans: The main players in the AI In Clinical Trials Market are Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn Al, PathAl, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs lInc

What are the Application segmentation covered in the AI In Clinical Trials Market report?

Ans: The Applications covered in the AI In Clinical Trials Market report are Pharmaceutical and Biotechnology Companies, Contract Research Organization, Other

What are the Type segmentation covered in the AI In Clinical Trials Market report?

Ans: The Types covered in the AI In Clinical Trials Market report are Software, Service

Recommended Reports

AI in Clinical Trials

Healthcare AI Solutions

AI Medical Imaging

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI In Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software
1.2.3 Service
1.3 Market by Application
1.3.1 Global AI In Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Contract Research Organization
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI In Clinical Trials Market Perspective (2020-2031)
2.2 Global AI In Clinical Trials Growth Trends by Region
2.2.1 Global AI In Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI In Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 AI In Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 AI In Clinical Trials Market Dynamics
2.3.1 AI In Clinical Trials Industry Trends
2.3.2 AI In Clinical Trials Market Drivers
2.3.3 AI In Clinical Trials Market Challenges
2.3.4 AI In Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI In Clinical Trials Players by Revenue
3.1.1 Global Top AI In Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global AI In Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global AI In Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI In Clinical Trials Revenue
3.4 Global AI In Clinical Trials Market Concentration Ratio
3.4.1 Global AI In Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI In Clinical Trials Revenue in 2024
3.5 Global Key Players of AI In Clinical Trials Head office and Area Served
3.6 Global Key Players of AI In Clinical Trials, Product and Application
3.7 Global Key Players of AI In Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI In Clinical Trials Breakdown Data by Type
4.1 Global AI In Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global AI In Clinical Trials Forecasted Market Size by Type (2026-2031)
5 AI In Clinical Trials Breakdown Data by Application
5.1 Global AI In Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global AI In Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI In Clinical Trials Market Size (2020-2031)
6.2 North America AI In Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI In Clinical Trials Market Size by Country (2020-2025)
6.4 North America AI In Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI In Clinical Trials Market Size (2020-2031)
7.2 Europe AI In Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI In Clinical Trials Market Size by Country (2020-2025)
7.4 Europe AI In Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI In Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific AI In Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI In Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific AI In Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI In Clinical Trials Market Size (2020-2031)
9.2 Latin America AI In Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI In Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America AI In Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI In Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa AI In Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI In Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa AI In Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intel
11.1.1 Intel Company Details
11.1.2 Intel Business Overview
11.1.3 Intel AI In Clinical Trials Introduction
11.1.4 Intel Revenue in AI In Clinical Trials Business (2020-2025)
11.1.5 Intel Recent Development
11.2 The International Business Machines Corporation(IBM)
11.2.1 The International Business Machines Corporation(IBM) Company Details
11.2.2 The International Business Machines Corporation(IBM) Business Overview
11.2.3 The International Business Machines Corporation(IBM) AI In Clinical Trials Introduction
11.2.4 The International Business Machines Corporation(IBM) Revenue in AI In Clinical Trials Business (2020-2025)
11.2.5 The International Business Machines Corporation(IBM) Recent Development
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Details
11.3.2 Koninklijke Philips N.V. Business Overview
11.3.3 Koninklijke Philips N.V. AI In Clinical Trials Introduction
11.3.4 Koninklijke Philips N.V. Revenue in AI In Clinical Trials Business (2020-2025)
11.3.5 Koninklijke Philips N.V. Recent Development
11.4 ConcertAl
11.4.1 ConcertAl Company Details
11.4.2 ConcertAl Business Overview
11.4.3 ConcertAl AI In Clinical Trials Introduction
11.4.4 ConcertAl Revenue in AI In Clinical Trials Business (2020-2025)
11.4.5 ConcertAl Recent Development
11.5 Saama Technologies LLC
11.5.1 Saama Technologies LLC Company Details
11.5.2 Saama Technologies LLC Business Overview
11.5.3 Saama Technologies LLC AI In Clinical Trials Introduction
11.5.4 Saama Technologies LLC Revenue in AI In Clinical Trials Business (2020-2025)
11.5.5 Saama Technologies LLC Recent Development
11.6 Samaa Technologies
11.6.1 Samaa Technologies Company Details
11.6.2 Samaa Technologies Business Overview
11.6.3 Samaa Technologies AI In Clinical Trials Introduction
11.6.4 Samaa Technologies Revenue in AI In Clinical Trials Business (2020-2025)
11.6.5 Samaa Technologies Recent Development
11.7 Owkin Inc.
11.7.1 Owkin Inc. Company Details
11.7.2 Owkin Inc. Business Overview
11.7.3 Owkin Inc. AI In Clinical Trials Introduction
11.7.4 Owkin Inc. Revenue in AI In Clinical Trials Business (2020-2025)
11.7.5 Owkin Inc. Recent Development
11.8 Numerate
11.8.1 Numerate Company Details
11.8.2 Numerate Business Overview
11.8.3 Numerate AI In Clinical Trials Introduction
11.8.4 Numerate Revenue in AI In Clinical Trials Business (2020-2025)
11.8.5 Numerate Recent Development
11.9 Neuroute
11.9.1 Neuroute Company Details
11.9.2 Neuroute Business Overview
11.9.3 Neuroute AI In Clinical Trials Introduction
11.9.4 Neuroute Revenue in AI In Clinical Trials Business (2020-2025)
11.9.5 Neuroute Recent Development
11.10 AiCure
11.10.1 AiCure Company Details
11.10.2 AiCure Business Overview
11.10.3 AiCure AI In Clinical Trials Introduction
11.10.4 AiCure Revenue in AI In Clinical Trials Business (2020-2025)
11.10.5 AiCure Recent Development
11.11 Ardigen
11.11.1 Ardigen Company Details
11.11.2 Ardigen Business Overview
11.11.3 Ardigen AI In Clinical Trials Introduction
11.11.4 Ardigen Revenue in AI In Clinical Trials Business (2020-2025)
11.11.5 Ardigen Recent Development
11.12 Unlearn Al
11.12.1 Unlearn Al Company Details
11.12.2 Unlearn Al Business Overview
11.12.3 Unlearn Al AI In Clinical Trials Introduction
11.12.4 Unlearn Al Revenue in AI In Clinical Trials Business (2020-2025)
11.12.5 Unlearn Al Recent Development
11.13 PathAl
11.13.1 PathAl Company Details
11.13.2 PathAl Business Overview
11.13.3 PathAl AI In Clinical Trials Introduction
11.13.4 PathAl Revenue in AI In Clinical Trials Business (2020-2025)
11.13.5 PathAl Recent Development
11.14 Exscentia
11.14.1 Exscentia Company Details
11.14.2 Exscentia Business Overview
11.14.3 Exscentia AI In Clinical Trials Introduction
11.14.4 Exscentia Revenue in AI In Clinical Trials Business (2020-2025)
11.14.5 Exscentia Recent Development
11.15 Aitia Infotech Pvt Ltd.
11.15.1 Aitia Infotech Pvt Ltd. Company Details
11.15.2 Aitia Infotech Pvt Ltd. Business Overview
11.15.3 Aitia Infotech Pvt Ltd. AI In Clinical Trials Introduction
11.15.4 Aitia Infotech Pvt Ltd. Revenue in AI In Clinical Trials Business (2020-2025)
11.15.5 Aitia Infotech Pvt Ltd. Recent Development
11.16 Euretos
11.16.1 Euretos Company Details
11.16.2 Euretos Business Overview
11.16.3 Euretos AI In Clinical Trials Introduction
11.16.4 Euretos Revenue in AI In Clinical Trials Business (2020-2025)
11.16.5 Euretos Recent Development
11.17 VeriSIM Life
11.17.1 VeriSIM Life Company Details
11.17.2 VeriSIM Life Business Overview
11.17.3 VeriSIM Life AI In Clinical Trials Introduction
11.17.4 VeriSIM Life Revenue in AI In Clinical Trials Business (2020-2025)
11.17.5 VeriSIM Life Recent Development
11.18 Envisagenics
11.18.1 Envisagenics Company Details
11.18.2 Envisagenics Business Overview
11.18.3 Envisagenics AI In Clinical Trials Introduction
11.18.4 Envisagenics Revenue in AI In Clinical Trials Business (2020-2025)
11.18.5 Envisagenics Recent Development
11.19 NURITAs
11.19.1 NURITAs Company Details
11.19.2 NURITAs Business Overview
11.19.3 NURITAs AI In Clinical Trials Introduction
11.19.4 NURITAs Revenue in AI In Clinical Trials Business (2020-2025)
11.19.5 NURITAs Recent Development
11.20 BioSymetrics
11.20.1 BioSymetrics Company Details
11.20.2 BioSymetrics Business Overview
11.20.3 BioSymetrics AI In Clinical Trials Introduction
11.20.4 BioSymetrics Revenue in AI In Clinical Trials Business (2020-2025)
11.20.5 BioSymetrics Recent Development
11.21 BioAge Labs lInc
11.21.1 BioAge Labs lInc Company Details
11.21.2 BioAge Labs lInc Business Overview
11.21.3 BioAge Labs lInc AI In Clinical Trials Introduction
11.21.4 BioAge Labs lInc Revenue in AI In Clinical Trials Business (2020-2025)
11.21.5 BioAge Labs lInc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI In Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Software
 Table 3. Key Players of Service
 Table 4. Global AI In Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global AI In Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global AI In Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global AI In Clinical Trials Market Share by Region (2020-2025)
 Table 8. Global AI In Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global AI In Clinical Trials Market Share by Region (2026-2031)
 Table 10. AI In Clinical Trials Market Trends
 Table 11. AI In Clinical Trials Market Drivers
 Table 12. AI In Clinical Trials Market Challenges
 Table 13. AI In Clinical Trials Market Restraints
 Table 14. Global AI In Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global AI In Clinical Trials Market Share by Players (2020-2025)
 Table 16. Global Top AI In Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Clinical Trials as of 2024)
 Table 17. Ranking of Global Top AI In Clinical Trials Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by AI In Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of AI In Clinical Trials, Headquarters and Area Served
 Table 20. Global Key Players of AI In Clinical Trials, Product and Application
 Table 21. Global Key Players of AI In Clinical Trials, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global AI In Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global AI In Clinical Trials Revenue Market Share by Type (2020-2025)
 Table 25. Global AI In Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global AI In Clinical Trials Revenue Market Share by Type (2026-2031)
 Table 27. Global AI In Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global AI In Clinical Trials Revenue Market Share by Application (2020-2025)
 Table 29. Global AI In Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global AI In Clinical Trials Revenue Market Share by Application (2026-2031)
 Table 31. North America AI In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America AI In Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America AI In Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe AI In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe AI In Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe AI In Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific AI In Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific AI In Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific AI In Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America AI In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America AI In Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America AI In Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa AI In Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa AI In Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa AI In Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Intel Company Details
 Table 47. Intel Business Overview
 Table 48. Intel AI In Clinical Trials Product
 Table 49. Intel Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 50. Intel Recent Development
 Table 51. The International Business Machines Corporation(IBM) Company Details
 Table 52. The International Business Machines Corporation(IBM) Business Overview
 Table 53. The International Business Machines Corporation(IBM) AI In Clinical Trials Product
 Table 54. The International Business Machines Corporation(IBM) Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 55. The International Business Machines Corporation(IBM) Recent Development
 Table 56. Koninklijke Philips N.V. Company Details
 Table 57. Koninklijke Philips N.V. Business Overview
 Table 58. Koninklijke Philips N.V. AI In Clinical Trials Product
 Table 59. Koninklijke Philips N.V. Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 60. Koninklijke Philips N.V. Recent Development
 Table 61. ConcertAl Company Details
 Table 62. ConcertAl Business Overview
 Table 63. ConcertAl AI In Clinical Trials Product
 Table 64. ConcertAl Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 65. ConcertAl Recent Development
 Table 66. Saama Technologies LLC Company Details
 Table 67. Saama Technologies LLC Business Overview
 Table 68. Saama Technologies LLC AI In Clinical Trials Product
 Table 69. Saama Technologies LLC Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 70. Saama Technologies LLC Recent Development
 Table 71. Samaa Technologies Company Details
 Table 72. Samaa Technologies Business Overview
 Table 73. Samaa Technologies AI In Clinical Trials Product
 Table 74. Samaa Technologies Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 75. Samaa Technologies Recent Development
 Table 76. Owkin Inc. Company Details
 Table 77. Owkin Inc. Business Overview
 Table 78. Owkin Inc. AI In Clinical Trials Product
 Table 79. Owkin Inc. Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 80. Owkin Inc. Recent Development
 Table 81. Numerate Company Details
 Table 82. Numerate Business Overview
 Table 83. Numerate AI In Clinical Trials Product
 Table 84. Numerate Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 85. Numerate Recent Development
 Table 86. Neuroute Company Details
 Table 87. Neuroute Business Overview
 Table 88. Neuroute AI In Clinical Trials Product
 Table 89. Neuroute Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 90. Neuroute Recent Development
 Table 91. AiCure Company Details
 Table 92. AiCure Business Overview
 Table 93. AiCure AI In Clinical Trials Product
 Table 94. AiCure Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 95. AiCure Recent Development
 Table 96. Ardigen Company Details
 Table 97. Ardigen Business Overview
 Table 98. Ardigen AI In Clinical Trials Product
 Table 99. Ardigen Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 100. Ardigen Recent Development
 Table 101. Unlearn Al Company Details
 Table 102. Unlearn Al Business Overview
 Table 103. Unlearn Al AI In Clinical Trials Product
 Table 104. Unlearn Al Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 105. Unlearn Al Recent Development
 Table 106. PathAl Company Details
 Table 107. PathAl Business Overview
 Table 108. PathAl AI In Clinical Trials Product
 Table 109. PathAl Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 110. PathAl Recent Development
 Table 111. Exscentia Company Details
 Table 112. Exscentia Business Overview
 Table 113. Exscentia AI In Clinical Trials Product
 Table 114. Exscentia Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 115. Exscentia Recent Development
 Table 116. Aitia Infotech Pvt Ltd. Company Details
 Table 117. Aitia Infotech Pvt Ltd. Business Overview
 Table 118. Aitia Infotech Pvt Ltd. AI In Clinical Trials Product
 Table 119. Aitia Infotech Pvt Ltd. Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 120. Aitia Infotech Pvt Ltd. Recent Development
 Table 121. Euretos Company Details
 Table 122. Euretos Business Overview
 Table 123. Euretos AI In Clinical Trials Product
 Table 124. Euretos Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 125. Euretos Recent Development
 Table 126. VeriSIM Life Company Details
 Table 127. VeriSIM Life Business Overview
 Table 128. VeriSIM Life AI In Clinical Trials Product
 Table 129. VeriSIM Life Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 130. VeriSIM Life Recent Development
 Table 131. Envisagenics Company Details
 Table 132. Envisagenics Business Overview
 Table 133. Envisagenics AI In Clinical Trials Product
 Table 134. Envisagenics Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 135. Envisagenics Recent Development
 Table 136. NURITAs Company Details
 Table 137. NURITAs Business Overview
 Table 138. NURITAs AI In Clinical Trials Product
 Table 139. NURITAs Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 140. NURITAs Recent Development
 Table 141. BioSymetrics Company Details
 Table 142. BioSymetrics Business Overview
 Table 143. BioSymetrics AI In Clinical Trials Product
 Table 144. BioSymetrics Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 145. BioSymetrics Recent Development
 Table 146. BioAge Labs lInc Company Details
 Table 147. BioAge Labs lInc Business Overview
 Table 148. BioAge Labs lInc AI In Clinical Trials Product
 Table 149. BioAge Labs lInc Revenue in AI In Clinical Trials Business (2020-2025) & (US$ Million)
 Table 150. BioAge Labs lInc Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. AI In Clinical Trials Picture
 Figure 2. Global AI In Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AI In Clinical Trials Market Share by Type: 2024 VS 2031
 Figure 4. Software Features
 Figure 5. Service Features
 Figure 6. Global AI In Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global AI In Clinical Trials Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
 Figure 9. Contract Research Organization Case Studies
 Figure 10. Other Case Studies
 Figure 11. AI In Clinical Trials Report Years Considered
 Figure 12. Global AI In Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global AI In Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global AI In Clinical Trials Market Share by Region: 2024 VS 2031
 Figure 15. Global AI In Clinical Trials Market Share by Players in 2024
 Figure 16. Global Top AI In Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Clinical Trials as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by AI In Clinical Trials Revenue in 2024
 Figure 18. North America AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America AI In Clinical Trials Market Share by Country (2020-2031)
 Figure 20. United States AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe AI In Clinical Trials Market Share by Country (2020-2031)
 Figure 24. Germany AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific AI In Clinical Trials Market Share by Region (2020-2031)
 Figure 32. China AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America AI In Clinical Trials Market Share by Country (2020-2031)
 Figure 40. Mexico AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa AI In Clinical Trials Market Share by Country (2020-2031)
 Figure 44. Turkey AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE AI In Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Intel Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 48. The International Business Machines Corporation(IBM) Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 49. Koninklijke Philips N.V. Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 50. ConcertAl Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 51. Saama Technologies LLC Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 52. Samaa Technologies Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 53. Owkin Inc. Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 54. Numerate Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 55. Neuroute Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 56. AiCure Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 57. Ardigen Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 58. Unlearn Al Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 59. PathAl Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 60. Exscentia Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 61. Aitia Infotech Pvt Ltd. Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 62. Euretos Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 63. VeriSIM Life Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 64. Envisagenics Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 65. NURITAs Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 66. BioSymetrics Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 67. BioAge Labs lInc Revenue Growth Rate in AI In Clinical Trials Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Cord Blood Processing System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-36T16872
Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Emotional Health Monitoring Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6J17145
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Endpoint Adjudication Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-17S17057
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Medical Speech Recognition System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-34I16915
Wed Nov 05 00:00:00 UTC 2025

Add to Cart